• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer.MicroRNA-155 对于效应性 CD8+ T 细胞应对病毒感染和癌症是必需的。
Immunity. 2013 Apr 18;38(4):742-53. doi: 10.1016/j.immuni.2012.12.006.
2
Out-of-sequence signal 3 as a mechanism for virus-induced immune suppression of CD8 T cell responses.乱序信号3作为病毒诱导的CD8 T细胞反应免疫抑制的一种机制。
PLoS Pathog. 2014 Sep 25;10(9):e1004357. doi: 10.1371/journal.ppat.1004357. eCollection 2014 Sep.
3
Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8(+) Cytolytic T Cell Responses.糖原合酶激酶3失活驱动T-bet介导的共受体PD-1下调以增强CD8(+) 细胞毒性T细胞反应。
Immunity. 2016 Feb 16;44(2):274-86. doi: 10.1016/j.immuni.2016.01.018.
4
Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.细胞因子信号转导抑制因子1的过表达可保护胰岛β细胞免受CD8 + T细胞介导的自身免疫破坏。
J Immunol. 2004 May 1;172(9):5714-21. doi: 10.4049/jimmunol.172.9.5714.
5
MyD88 plays a critical T cell-intrinsic role in supporting CD8 T cell expansion during acute lymphocytic choriomeningitis virus infection.在急性淋巴细胞性脉络丛脑膜炎病毒感染期间,MyD88在支持CD8 T细胞扩增方面发挥关键的T细胞内在作用。
J Immunol. 2008 Sep 15;181(6):3804-10. doi: 10.4049/jimmunol.181.6.3804.
6
Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections.急性、持续性和慢性病毒感染期间T细胞反应的维持、丧失及复苏。
J Immunol. 2004 Apr 1;172(7):4204-14. doi: 10.4049/jimmunol.172.7.4204.
7
Id3 Controls Cell Death of 2B4+ Virus-Specific CD8+ T Cells in Chronic Viral Infection.Id3调控慢性病毒感染中2B4 +病毒特异性CD8 + T细胞的细胞死亡。
J Immunol. 2015 Sep 1;195(5):2103-14. doi: 10.4049/jimmunol.1402607. Epub 2015 Jul 31.
8
Mast Cells Modulate Antigen-Specific CD8 T Cell Activation During LCMV Infection.肥大细胞在 LCMV 感染过程中调节抗原特异性 CD8 T 细胞的激活。
Front Immunol. 2021 Jun 14;12:688347. doi: 10.3389/fimmu.2021.688347. eCollection 2021.
9
Acute and chronic B cell depletion disrupts CD4+ and CD8+ T cell homeostasis and expansion during acute viral infection in mice.急性和慢性B细胞耗竭会破坏小鼠急性病毒感染期间CD4+和CD8+T细胞的稳态及增殖。
J Immunol. 2014 Jul 15;193(2):746-56. doi: 10.4049/jimmunol.1302848. Epub 2014 Jun 13.
10
STAT5 is critical to maintain effector CD8+ T cell responses.STAT5 对于维持效应性 CD8+T 细胞应答至关重要。
J Immunol. 2010 Aug 15;185(4):2116-24. doi: 10.4049/jimmunol.1000842. Epub 2010 Jul 19.

引用本文的文献

1
Prdm12 governs an epigenetic checkpoint linking neuroimmune cross-talk to CD8 T cell exhaustion-suppressed antitumor immunity.Prdm12 调控一个表观遗传检查点,该检查点将神经免疫相互作用与 CD8 T 细胞耗竭抑制的抗肿瘤免疫联系起来。
Sci Adv. 2025 Aug 15;11(33):eadx9221. doi: 10.1126/sciadv.adx9221.
2
Interplay between innate-like T-cells and microRNAs in cancer immunity.天然样T细胞与微小RNA在癌症免疫中的相互作用。
Discov Oncol. 2025 Jul 28;16(1):1425. doi: 10.1007/s12672-025-03234-3.
3
MicroRNAs in Cancer Immunology: Master Regulators of the Tumor Microenvironment and Immune Evasion, with Therapeutic Potential.癌症免疫学中的微小RNA:肿瘤微环境和免疫逃逸的主要调节因子,具有治疗潜力。
Cancers (Basel). 2025 Jun 27;17(13):2172. doi: 10.3390/cancers17132172.
4
MicroRNA expression profiles in sinonasal biopsies to support diagnosis of granulomatosis with polyangiitis.鼻旁窦活检组织中的微小RNA表达谱有助于支持显微镜下多血管炎的诊断。
Front Immunol. 2025 Apr 14;16:1579750. doi: 10.3389/fimmu.2025.1579750. eCollection 2025.
5
A microRNA-regulated transcriptional state defines intratumoral CD8 T cells that respond to immunotherapy.一种受微小RNA调控的转录状态定义了对免疫疗法有反应的肿瘤内CD8 T细胞。
Cell Rep. 2025 Feb 25;44(2):115301. doi: 10.1016/j.celrep.2025.115301. Epub 2025 Feb 12.
6
Exploring the regulatory role of small RNAs in modulating host-pathogen interactions: implications for bacterial and viral infections.探索小RNA在调节宿主-病原体相互作用中的调控作用:对细菌和病毒感染的影响。
Mol Biol Rep. 2025 Jan 12;52(1):115. doi: 10.1007/s11033-024-10214-3.
7
Unraveling the interplay of CD8 + T cells and microRNA signaling in cancer: implications for immune dysfunction and therapeutic approaches.解析癌症中CD8 + T细胞与微小RNA信号传导的相互作用:对免疫功能障碍和治疗方法的启示
J Transl Med. 2024 Dec 20;22(1):1131. doi: 10.1186/s12967-024-05963-5.
8
INT-1B3, an LNP formulated miR-193a-3p mimic, promotes anti-tumor immunity by enhancing T cell mediated immune responses via modulation of the tumor microenvironment and induction of immunogenic cell death.INT-1B3,一种 LNP 包裹的 miR-193a-3p 模拟物,通过调节肿瘤微环境和诱导免疫原性细胞死亡,增强 T 细胞介导的免疫反应,从而促进抗肿瘤免疫。
Oncotarget. 2024 Jul 12;15:470-485. doi: 10.18632/oncotarget.28608.
9
Reactive oxygen species/glutathione dual sensitive nanoparticles with encapsulation of miR155 and curcumin for synergized cancer immunotherapy.具有 miR155 和姜黄素包封的活性氧/谷胱甘肽双敏感纳米颗粒用于协同癌症免疫治疗。
J Nanobiotechnology. 2024 Jul 8;22(1):400. doi: 10.1186/s12951-024-02575-5.
10
The role of regulatory T cells in vitiligo and therapeutic advances: a mini-review.调节性 T 细胞在白癜风中的作用及治疗进展:迷你综述。
Inflamm Res. 2024 Aug;73(8):1311-1332. doi: 10.1007/s00011-024-01900-w. Epub 2024 Jun 5.

本文引用的文献

1
The role of interleukin-2 during homeostasis and activation of the immune system.白细胞介素-2 在免疫系统稳态和激活中的作用。
Nat Rev Immunol. 2012 Feb 17;12(3):180-90. doi: 10.1038/nri3156.
2
Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation.解析 miR-17-92 簇在促进 Th1 反应和防止诱导性 Treg 分化中的关键双重作用的分子机制。
Blood. 2011 Nov 17;118(20):5487-97. doi: 10.1182/blood-2011-05-355644. Epub 2011 Oct 4.
3
CD8(+) T cells: foot soldiers of the immune system.CD8(+) T 细胞:免疫系统的步兵。
Immunity. 2011 Aug 26;35(2):161-8. doi: 10.1016/j.immuni.2011.07.010.
4
Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis.沉默 microRNA-155 可改善实验性自身免疫性脑脊髓炎。
J Immunol. 2011 Sep 1;187(5):2213-21. doi: 10.4049/jimmunol.1003952. Epub 2011 Jul 25.
5
Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice.影响小鼠体内大型已建立肿瘤的 CD8+ T 细胞过继免疫治疗效果的因素。
Clin Cancer Res. 2011 Aug 15;17(16):5343-52. doi: 10.1158/1078-0432.CCR-11-0503. Epub 2011 Jul 7.
6
MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis.微小 RNA-155 在临床和实验性关节炎中的促炎调节作用。
Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11193-8. doi: 10.1073/pnas.1019536108. Epub 2011 Jun 20.
7
Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets.体内人类 CD8+ T 细胞亚群中与分化相关的 microRNA 表达调控。
J Transl Med. 2011 Apr 20;9:44. doi: 10.1186/1479-5876-9-44.
8
A parsimonious model for gene regulation by miRNAs.miRNAs 调控基因的简约模型。
Science. 2011 Feb 4;331(6017):550-3. doi: 10.1126/science.1191138.
9
Dicer controls CD8+ T-cell activation, migration, and survival.Dicer 控制 CD8+ T 细胞的激活、迁移和存活。
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21629-34. doi: 10.1073/pnas.1016299107. Epub 2010 Nov 22.
10
The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1).人巨噬细胞中的白细胞介素 13(IL-13)途径受 microRNA-155 通过直接靶向白细胞介素 13 受体 alpha1(IL13Ralpha1)的调节。
J Biol Chem. 2011 Jan 21;286(3):1786-94. doi: 10.1074/jbc.M110.169367. Epub 2010 Nov 19.

MicroRNA-155 对于效应性 CD8+ T 细胞应对病毒感染和癌症是必需的。

MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer.

机构信息

Ludwig Center for Cancer Research, University of Lausanne, 1066 Epalinges, Switzerland.

出版信息

Immunity. 2013 Apr 18;38(4):742-53. doi: 10.1016/j.immuni.2012.12.006.

DOI:10.1016/j.immuni.2012.12.006
PMID:23601686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3788592/
Abstract

MicroRNAs (miRNAs) regulate the function of several immune cells, but their role in promoting CD8(+) T cell immunity remains unknown. Here we report that miRNA-155 is required for CD8(+) T cell responses to both virus and cancer. In the absence of miRNA-155, accumulation of effector CD8(+) T cells was severely reduced during acute and chronic viral infections and control of virus replication was impaired. Similarly, Mir155(-/-) CD8(+) T cells were ineffective at controlling tumor growth, whereas miRNA-155 overexpression enhanced the antitumor response. miRNA-155 deficiency resulted in accumulation of suppressor of cytokine signaling-1 (SOCS-1) causing defective cytokine signaling through STAT5. Consistently, enforced expression of SOCS-1 in CD8(+) T cells phenocopied the miRNA-155 deficiency, whereas SOCS-1 silencing augmented tumor destruction. These findings identify miRNA-155 and its target SOCS-1 as key regulators of effector CD8(+) T cells that can be modulated to potentiate immunotherapies for infectious diseases and cancer.

摘要

微小 RNA(miRNAs)调节多种免疫细胞的功能,但它们在促进 CD8(+)T 细胞免疫中的作用尚不清楚。在这里,我们报告 miRNA-155 是 CD8(+)T 细胞对病毒和癌症反应所必需的。在缺乏 miRNA-155 的情况下,效应性 CD8(+)T 细胞在急性和慢性病毒感染期间的积累严重减少,病毒复制的控制受到损害。同样,Mir155(-/-)CD8(+)T 细胞在控制肿瘤生长方面无效,而 miRNA-155 的过表达增强了抗肿瘤反应。miRNA-155 缺乏导致细胞因子信号转导抑制因子-1(SOCS-1)的积累,从而导致通过 STAT5 的细胞因子信号转导缺陷。一致地,SOCS-1 在 CD8(+)T 细胞中的强制表达可模拟 miRNA-155 的缺乏,而 SOCS-1 的沉默则增强了肿瘤的破坏。这些发现确定了 miRNA-155 和其靶基因 SOCS-1 是效应性 CD8(+)T 细胞的关键调节因子,可以通过调节它们来增强针对传染病和癌症的免疫疗法。